Search Results - "Benn, Carol A"

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Dysregulation of systemic soluble immune checkpoints in early breast cancer is attenuated following administration of neoadjuvant chemotherapy and is associated with recovery of CD27, CD28, CD40, CD80, ICOS and GITR and substantially increased levels of PD-L1, LAG-3 and TIM-3

    Dysregulation of systemic soluble immune checkpoints in early breast cancer is attenuated following administration of neoadjuvant chemotherapy and is associated with recovery of CD27, CD28, CD40, CD80, ICOS and GITR and substantially increased levels of PD-L1, LAG-3 and TIM-3 by Rapoport, Bernardo L, Steel, Helen C, Benn, Carol A, Nayler, Simon, Smit, Teresa, Heyman, Liezl, Theron, Annette J, Hlatshwayo, Nomsa, Kwofie, Luyanda L I, Meyer, Pieter W A, Anderson, Ronald

    Published in Frontiers in oncology (30-03-2023)
    “…Neoadjuvant chemotherapy (NAC) may alter the immune landscape of patients with early breast cancer (BC), potentially setting the scene for more effective…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  2. 2
    When and How Do I Use Neoadjuvant Chemotherapy for Breast Cancer?

    When and How Do I Use Neoadjuvant Chemotherapy for Breast Cancer? by Rapoport, Bernardo L., Demetriou, Georgia S., Moodley, Shun D., Benn, Carol A.

    Published in Current treatment options in oncology (01-03-2014)
    “…Opinion statement Systemic neoadjuvant chemotherapy is utilized along with surgery and radiotherapy for the management of patients with locally advanced breast…”
    Get full text
    Journal Article
    Save to List
    Saved in:

Search Tools: